<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01457014</url>
  </required_header>
  <id_info>
    <org_study_id>SDBPM-2011-01</org_study_id>
    <nct_id>NCT01457014</nct_id>
  </id_info>
  <brief_title>Sleep Disordered Breathing and Chronic Pain</brief_title>
  <official_title>BiPAP Adaptive Servo-Ventilation (AutoSV) Therapy in Patients With Chronic Pain and Sleep Disordered Breathing (SDB)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philips Respironics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philips Respironics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate positive pressure in patients with chronic pain
      taking opioid medications who have sleep disordered breathing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Purpose: Opioid treatment of non-malignant chronic pain can result in hypoxemia, hypercarbia,
      and central sleep apnea. The aim of this study was to determine the initial efficacy of auto
      servo-ventilation (ASV) and after 3 months of home use.

      Methods: This prospective multicenter interventional study recruited chronic pain patients
      prescribed ≥100 morphine equivalents for at least 4 months.

      Participants: Following full-night polysomnography (PSG) to confirm the presence of
      sleep-disordered breathing, patients were randomized to three additional full-night-attended
      PSGs with continuous positive airway pressure (CPAP), ASV, and servo-ventilation with an
      initial mandatory pressure support of 6 cm water (H2O) ASV manual Minimum Pressure Support
      (PSmin). Following the PSGs, patients were sent home with EncoreAnywhere and ASV with or
      without mandatory pressure support.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2011</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Sleep Related Events Per Hour</measure>
    <time_frame>four full night Polysomnography (PSG's)</time_frame>
    <description>The number of Apnea-Hypopnea Events, Central Apneas, Obstructive Apneas and Hypopneas were compared among no treatment, CPAP, Auto SV and Manual SV.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percent Oxygen Saturation</measure>
    <time_frame>four full night Polysomnography (PSG's)</time_frame>
    <description>Oxygen Saturation were compared among using no treatment, CPAP, Auto SV and Manual SV.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Arterial Oxygen Saturation Per Hour</measure>
    <time_frame>four full night Polysomnography (PSG's)</time_frame>
    <description>Arterial Oxygen Saturation was compared among using no treatment, CPAP, Auto SV and Manual SV.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Sleep Apnea Syndromes</condition>
  <arm_group>
    <arm_group_label>servo ventilation auto mode</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Inspiratory and expiratory pressures automatically determined by the servo ventilation device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous positive airway pressure</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Airway pressure delivered at a constant pressure level.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>servo ventilation manual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Inspiratory and expiratory pressures automatically determined by the servo ventilation device with mandatory minimal inspiratory minus expiratory pressure difference.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>servo ventilation auto</intervention_name>
    <description>Expiratory pressure automatically adjusted to stabilize the upper airway. Inspiratory pressure automatically adjusted to deliver consistent peak flow.</description>
    <arm_group_label>servo ventilation auto mode</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Continuous positive airway pressure</intervention_name>
    <description>continuous positive airway pressure</description>
    <arm_group_label>servo ventilation auto mode</arm_group_label>
    <arm_group_label>Continuous positive airway pressure</arm_group_label>
    <other_name>CPAP</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>servo ventilation manual</intervention_name>
    <description>servo ventilation titrated in manual mode</description>
    <arm_group_label>servo ventilation auto mode</arm_group_label>
    <arm_group_label>Continuous positive airway pressure</arm_group_label>
    <arm_group_label>servo ventilation manual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Males and females, ages 21-70.

          2. Able to provide written informed consent.

          3. Diagnosis of chronic non-malignant pain (pain present for ≥ 6 months).

          4. Stable regimen of opioids (oral, transdermal, and/or intravenous) for chronic pain for
             at least 4 weeks prior to study participation with a prescribed opioid dose equal to
             at least 100 milliequivalents of morphine per 24 hours (Appendix 1).

          5. Agreement to undergo an in-lab Diagnostic polysomnography (PSG) demonstrating an
             Apnea-Hypopnea Index (AHI) of at least 20 and Central Apnea Index (CAI) ≥ 10 events
             per hour of sleep OR at least 25% of Total Sleep Time (TST) below 90% Oxygen
             Saturation (SAO2) saturation and AHI ≥ 10

          6. Agreement to undergo 3 full-night, in-lab PSG's on positive airway pressure therapy.

          7. Agreement to undergo breathalyzer testing prior to each PSG visit

          8. Ability to provide reliable documentation of opioid medications (ex. Pharmacy records)
             as treatment for chronic pain for the previous 30 days.

          9. Willingness to undergo urine drug screening.

        Exclusion Criteria:

          1. Participation in other interventional, sleep or pharmaceutical related research
             studies within 30 days prior to giving consent.

          2. Workers with variable shift schedules.

          3. Previous treatment with positive airway pressure therapy within 90 days of providing
             consent.

          4. Participants with any conditions in which positive airway pressure is medically
             contraindicated (e.g. recent pneumothorax, systolic BP &lt; 80 mmHg).

          5. BMI &gt; 40

          6. Unwilling to wear PAP.

          7. Any surgery involving the upper airway, eye, nose, sinuses or middle ear within the
             last 90 days.

          8. Major or poorly managed medical or psychiatric condition that would interfere with the
             demands of the study, to the use of positive airway pressure, or the ability to
             complete the study.

          9. Previous diagnosis of severe chronic obstructive pulmonary disease (COPD) with an
             forced expiratory volume at one second (FEV1) &lt; 1 liter or less than 50% predicted

         10. Presence of elevated arterial carbon dioxide levels while awake (PaCO2 ≥ 50mmHg) due
             to intrinsic lung disease, neuromuscular or musculoskeletal disorders.

         11. Participants currently prescribed 24 hour oxygen therapy (nocturnal O2 therapy for
             obstructive sleep apnea (OSA) treatment is allowed)

         12. Females who are pregnant or, if of child bearing potential, not currently using
             medically reliable birth control methods.

         13. Participants prescribed opioids for reasons other than the management of chronic,
             non-malignant pain.

         14. Failure of two consecutive breathalyzer tests from study PSG nights

         15. Periodic Limb Movements (PLM's) with arousals &gt; 15
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul Wylie, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arkansas Center of Sleep Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vernon Pegram, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sleep D/O Center of Alabama</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mark Muehlbach, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clayton Sleep Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Russell Rosenberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NeuroTrials Research, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sleep D/O Center of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Center for Sleep Medicine</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NeuroTrials Research Inc.</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30342</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clayton Sleep Institute</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 30, 2011</study_first_submitted>
  <study_first_submitted_qc>October 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2011</study_first_posted>
  <results_first_submitted>October 29, 2015</results_first_submitted>
  <results_first_submitted_qc>January 22, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">February 19, 2016</results_first_posted>
  <last_update_submitted>January 22, 2016</last_update_submitted>
  <last_update_submitted_qc>January 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic pain</keyword>
  <keyword>sleep disordered breathing</keyword>
  <keyword>Opioids</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Participants were recruited from pain treatment centers and clinics by either Pain Center/Clinic staff or staff from a Sleep Testing facility.</recruitment_details>
      <pre_assignment_details>74 participants were screened; 40 were excluded after completing the diagnostic PSG (did not meet the inclusion/exclusion criteria).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Diagnostic Polysomnography (PSG)</title>
          <description>A Diagnostic PSG was performed using the core equipment available to determine eligibility into the overnight portion of the study.</description>
        </group>
        <group group_id="P2">
          <title>Continuous Positive Airway Pressure (CPAP)</title>
          <description>Airway pressure delivered at a constant pressure level.
CPAP: continuous positive airway pressure
servo ventilation manual: servo ventilation titrated in manual mode</description>
        </group>
        <group group_id="P3">
          <title>Servo Ventilation Auto Mode (autoSV)</title>
          <description>Inspiratory and expiratory pressures automatically determined by the servo ventilation device.
servo ventilation auto: Expiratory pressure automatically adjusted to stabilize the upper airway. Inspiratory pressure automatically adjusted to deliver consistent peak flow.
CPAP: continuous positive airway pressure
servo ventilation manual: servo ventilation titrated in manual mode</description>
        </group>
        <group group_id="P4">
          <title>Servo Ventilation Manual (Manual SV)</title>
          <description>Inspiratory and expiratory pressures automatically determined by the servo ventilation device with mandatory minimal inspiratory minus expiratory pressure difference.
servo ventilation manual: servo ventilation titrated in manual mode</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Night</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="74"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="40"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Didn't meet inclusion/exclusion criteria</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Second Night</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0">The Diagnostic PSG was only completed on the First night</participants>
                <participants group_id="P2" count="12">Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.</participants>
                <participants group_id="P3" count="11">Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.</participants>
                <participants group_id="P4" count="11">Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0">The Diagnostic PSG was only completed on the First night</participants>
                <participants group_id="P2" count="12"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Third Night</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0">The Diagnostic PSG was only completed on the First night</participants>
                <participants group_id="P2" count="11">Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.</participants>
                <participants group_id="P3" count="11">Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.</participants>
                <participants group_id="P4" count="12">Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0">The Diagnostic PSG was only completed on the First night</participants>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="11"/>
                <participants group_id="P4" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Fourth Night</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0">The Diagnostic PSG was only completed on the First night</participants>
                <participants group_id="P2" count="11">Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.</participants>
                <participants group_id="P3" count="12">Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.</participants>
                <participants group_id="P4" count="11">Participants were randomized to different arms for each overnight stay: CPAP, Auto SV, Manual SV.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0">The Diagnostic PSG was only completed on the First night</participants>
                <participants group_id="P2" count="11"/>
                <participants group_id="P3" count="12"/>
                <participants group_id="P4" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Number of participants that completed the baseline PSG and were randomized for the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Total Group</title>
          <description>34 subjects completed part 1 of the study which consisted of diagnostic PSG screening and met all inclusion/exclusion criteria</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="50.7" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Caucasian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Morphine equivalents</title>
          <description>Calculate the total daily dose (24h) for each long acting and short acting opioid.
Divide the total daily dose for each opioid by its equianalgesic dose (ED) (see chart) to get the equianalgesic dose units (EDU).
Add the EDU for each opioid to get the total EDU for all opioids.
Multiply the total EDU by 30 mg to get the morphine equivalent dose (meq of morphine).
Opioid- ED Morphine- 30 Hydrocodone- 30 Oxycodone- 20 Hydromorphone- 7.5 Codeine- 200 Methadone- 2-4 (chronic opioid users) Meperidine- 300 Tramadol- 1:5 ratio whereas10 mg morphine = 50mg Tramadol</description>
          <units>mEq</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="390.1" spread="338.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Sleep Related Events Per Hour</title>
        <description>The number of Apnea-Hypopnea Events, Central Apneas, Obstructive Apneas and Hypopneas were compared among no treatment, CPAP, Auto SV and Manual SV.</description>
        <time_frame>four full night Polysomnography (PSG's)</time_frame>
        <population>After the Diagnostic Polysomnography (PSG) each participant completed a night in each arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Diagnostic Polysomnography (PSG)</title>
            <description>Baseline overnight Polysomnography (PSG)</description>
          </group>
          <group group_id="O2">
            <title>CPAP</title>
            <description>Airway pressure delivered at a constant pressure level.
CPAP: continuous positive airway pressure
servo ventilation manual: servo ventilation titrated in manual mode</description>
          </group>
          <group group_id="O3">
            <title>Servo Ventilation Auto Mode</title>
            <description>Inspiratory and expiratory pressures automatically determined by the servo ventilation device.
servo ventilation auto: Expiratory pressure automatically adjusted to stabilize the upper airway. Inspiratory pressure automatically adjusted to deliver consistent peak flow.
CPAP: continuous positive airway pressure
servo ventilation manual: servo ventilation titrated in manual mode</description>
          </group>
          <group group_id="O4">
            <title>Servo Ventilation Manual</title>
            <description>Inspiratory and expiratory pressures automatically determined by the servo ventilation device with mandatory minimal inspiratory minus expiratory pressure difference.
servo ventilation manual: servo ventilation titrated in manual mode</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Sleep Related Events Per Hour</title>
          <description>The number of Apnea-Hypopnea Events, Central Apneas, Obstructive Apneas and Hypopneas were compared among no treatment, CPAP, Auto SV and Manual SV.</description>
          <population>After the Diagnostic Polysomnography (PSG) each participant completed a night in each arm.</population>
          <units>events/hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
                <count group_id="O3" value="31"/>
                <count group_id="O4" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Apnea-hyopnea index</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38.8" spread="31.1"/>
                    <measurement group_id="O2" value="17.4" spread="20.1"/>
                    <measurement group_id="O3" value="4.5" spread="7.3"/>
                    <measurement group_id="O4" value="7.6" spread="16.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Central Apnea Index</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.1" spread="18.8"/>
                    <measurement group_id="O2" value="8.4" spread="12.4"/>
                    <measurement group_id="O3" value="0.2" spread="0.8"/>
                    <measurement group_id="O4" value="0.2" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Obstructive Apnea Index</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.7" spread="6.3"/>
                    <measurement group_id="O2" value="4.5" spread="6.3"/>
                    <measurement group_id="O3" value="0.3" spread="0.5"/>
                    <measurement group_id="O4" value="0.5" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hypopnea Index</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14.8" spread="12.6"/>
                    <measurement group_id="O2" value="4.5" spread="5.1"/>
                    <measurement group_id="O3" value="4.6" spread="7.4"/>
                    <measurement group_id="O4" value="7.9" spread="16.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>p values have undergone Bonferroni adjustment for Central Apnea Index (CAI), Obstructive Apnea Index (OAI) and Hypopnea Index (HI)</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Oxygen Saturation</title>
        <description>Oxygen Saturation were compared among using no treatment, CPAP, Auto SV and Manual SV.</description>
        <time_frame>four full night Polysomnography (PSG's)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Diagnostic PSG</title>
            <description>Baseline overnight PSG.</description>
          </group>
          <group group_id="O2">
            <title>CPAP</title>
            <description>Airway pressure delivered at a constant pressure level.
CPAP: continuous positive airway pressure
servo ventilation manual: servo ventilation titrated in manual mode</description>
          </group>
          <group group_id="O3">
            <title>Servo Ventilation Auto Mode</title>
            <description>Inspiratory and expiratory pressures automatically determined by the servo ventilation device.
servo ventilation auto: Expiratory pressure automatically adjusted to stabilize the upper airway. Inspiratory pressure automatically adjusted to deliver consistent peak flow.
CPAP: continuous positive airway pressure
servo ventilation manual: servo ventilation titrated in manual mode</description>
          </group>
          <group group_id="O4">
            <title>Servo Ventilation Manual</title>
            <description>Inspiratory and expiratory pressures automatically determined by the servo ventilation device with mandatory minimal inspiratory minus expiratory pressure difference.
servo ventilation manual: servo ventilation titrated in manual mode</description>
          </group>
        </group_list>
        <measure>
          <title>Percent Oxygen Saturation</title>
          <description>Oxygen Saturation were compared among using no treatment, CPAP, Auto SV and Manual SV.</description>
          <units>percentage of oxygen saturation</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
                <count group_id="O3" value="31"/>
                <count group_id="O4" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Av. O2 saturation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92.9" spread="3.4"/>
                    <measurement group_id="O2" value="94.6" spread="2.3"/>
                    <measurement group_id="O3" value="94.6" spread="2.6"/>
                    <measurement group_id="O4" value="94.5" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Min. O2 saturation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="79.9" spread="7.8"/>
                    <measurement group_id="O2" value="85.5" spread="6.0"/>
                    <measurement group_id="O3" value="82.9" spread="16.2"/>
                    <measurement group_id="O4" value="79.7" spread="22.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.627</p_value>
            <p_value_desc>p value has undergone Bonferroni adjustment. P-Value applies to Av. 02 saturation</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
            <method_desc>p value has undergone Bonferroni adjustment</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Arterial Oxygen Saturation Per Hour</title>
        <description>Arterial Oxygen Saturation was compared among using no treatment, CPAP, Auto SV and Manual SV.</description>
        <time_frame>four full night Polysomnography (PSG's)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Diagnostic PSG</title>
            <description>Baseline overnight PSG.</description>
          </group>
          <group group_id="O2">
            <title>CPAP</title>
            <description>Airway pressure delivered at a constant pressure level.
CPAP: continuous positive airway pressure
servo ventilation manual: servo ventilation titrated in manual mode</description>
          </group>
          <group group_id="O3">
            <title>Servo Ventilation Auto Mode</title>
            <description>Inspiratory and expiratory pressures automatically determined by the servo ventilation device.
servo ventilation auto: Expiratory pressure automatically adjusted to stabilize the upper airway. Inspiratory pressure automatically adjusted to deliver consistent peak flow.
CPAP: continuous positive airway pressure
servo ventilation manual: servo ventilation titrated in manual mode</description>
          </group>
          <group group_id="O4">
            <title>Servo Ventilation Manual</title>
            <description>Inspiratory and expiratory pressures automatically determined by the servo ventilation device with mandatory minimal inspiratory minus expiratory pressure difference.
servo ventilation manual: servo ventilation titrated in manual mode</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Arterial Oxygen Saturation Per Hour</title>
          <description>Arterial Oxygen Saturation was compared among using no treatment, CPAP, Auto SV and Manual SV.</description>
          <units>times per hour</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="31"/>
                <count group_id="O2" value="31"/>
                <count group_id="O3" value="31"/>
                <count group_id="O4" value="31"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.8" spread="29.2"/>
                    <measurement group_id="O2" value="15.1" spread="20.2"/>
                    <measurement group_id="O3" value="5.9" spread="8.6"/>
                    <measurement group_id="O4" value="9.5" spread="19.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.161</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Total Group</title>
          <description>34 subjects completed part 1 of the study which consisted of diagnostic PSG screening and met all inclusion/exclusion criteria</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Common Cold</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Sinus Infection</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="34"/>
              </event>
              <event>
                <sub_title>Ear Infection</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Sinus Congestion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Sharon A. Chung</name_or_title>
      <organization>Sleep and Alertness Research Inc.</organization>
      <phone>416-603-5275</phone>
      <email>sachung@uhnres.utoronto.ca</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

